Ginsenosides Regulate PXR/NF-κB Signaling and Attenuate Dextran Sulfate Sodium–Induced Colitis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Ginsenosides Regulate PXR/NF-κB Signaling and Attenuate Dextran Sulfate Sodium–Induced Colitis

Published:2015-05-18 Issue:8 Volume:43 Page:1181-1189
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Zhang Jun,Cao Lijuan,Wang Hong,Cheng Xuefang,Wang Lin,Zhu Lin,Yan Tingting,Xie Yang,Wu Yuzheng,Zhao Min,Ma Sijing,Wu Mengqiu,Wang Guangji,Hao Haiping

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference46 articles.

1. Drug Interaction Potential of Soy Extract and Panax Ginseng

2. NF-κB in inflammatory bowel disease

3. Ginseng pharmacology

4. PPARα contributes to colonic protection in mice with DSS-induced colitis

5. Decreased P-glycoprotein (P-gp/MDR1) expression in inflamed human intestinal epithelium is independent of PXR protein levels

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Activation of pregnane X receptor protects against cholestatic liver injury by inhibiting hepatocyte pyroptosis;Acta Pharmacologica Sinica;2024-08-07

2. Therapeutic effect of Sheng Mai San, a traditional Chinese medicine formula, on inflammatory bowel disease via inhibition of NF-κB and NLRP3 inflammasome signaling;Frontiers in Pharmacology;2024-08-02

3. Ginsenoside Rg1 protects the blood–brain barrier and myelin sheath to prevent postoperative cognitive dysfunction in aged mice;NeuroReport;2024-07-30

4. Ginsenosides from Panax ginseng as potential therapeutic candidates for the treatment of inflammatory bowel disease;Phytomedicine;2024-05

5. Terpenes: Modulating anti-inflammatory signaling in inflammatory bowel disease;Pharmacology & Therapeutics;2023-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3